Identification of anti-herpes simplex virus antibody-producing B cells in a patient with an atypical RAG1 immunodeficiency

Satoru Kumaki, Anna Villa, Hiroshi Asada, Shin Kawai, Yoshiyuki Ohashi, Miyoko Takahashi, Ikuko Hakozaki, Etsuko Nitanai, Masayoshi Minegishi, Shigeru Tsuchiya

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Mutations of the RAG1 or RAG2 protein that eliminate their recombination activity result in T-B-severe combined immunodeficiency (SCID), whereas mutations retaining partial recombination activity lead to Omenn syndrome, a peculiar SCID characterized by increased host T cells and absence of circulating B cells. The prognosis of this disease is fatal, unless hematopoietic stem cell transplantation is performed. This study reports a case of atypical SCID, carrying RAG1 mutations. The patient survived for 6 years without hematopoietic stem cell transplantation. The missense mutation, tested by in vivo recombination assay, revealed residual recombination activity. By the age of 5 years, the patient developed host B cells, but not T cells, possibly due to engrafted maternal T cells. In addition, the host B cells were able to produce antibodies, including anti-herpes simplex virus-antibodies. The fact that host B cells could produce antibodies in this patient could explain not only the mild phenotype observed but also, at least in part, how patients with Omenn syndrome produce immunoglobulin E and sometimes immunoglobulin M, as the same missense mutation of RAG1 gene has been reported in a patient with Omenn syndrome.

Original languageEnglish
Pages (from-to)1464-1468
Number of pages5
JournalBlood
Volume98
Issue number5
DOIs
Publication statusPublished - Sep 1 2001

Fingerprint

Severe Combined Immunodeficiency
Antibody-Producing Cells
Simplexvirus
Viruses
T-cells
B-Lymphocytes
Cells
Genetic Recombination
Antibodies
Stem cells
Immunoglobulin E
Hematopoietic Stem Cell Transplantation
Missense Mutation
T-Lymphocytes
Mutation
Immunoglobulin M
Assays
Genes
Anti-Idiotypic Antibodies
Mothers

ASJC Scopus subject areas

  • Hematology

Cite this

Identification of anti-herpes simplex virus antibody-producing B cells in a patient with an atypical RAG1 immunodeficiency. / Kumaki, Satoru; Villa, Anna; Asada, Hiroshi; Kawai, Shin; Ohashi, Yoshiyuki; Takahashi, Miyoko; Hakozaki, Ikuko; Nitanai, Etsuko; Minegishi, Masayoshi; Tsuchiya, Shigeru.

In: Blood, Vol. 98, No. 5, 01.09.2001, p. 1464-1468.

Research output: Contribution to journalArticle

Kumaki, S, Villa, A, Asada, H, Kawai, S, Ohashi, Y, Takahashi, M, Hakozaki, I, Nitanai, E, Minegishi, M & Tsuchiya, S 2001, 'Identification of anti-herpes simplex virus antibody-producing B cells in a patient with an atypical RAG1 immunodeficiency', Blood, vol. 98, no. 5, pp. 1464-1468. https://doi.org/10.1182/blood.V98.5.1464
Kumaki, Satoru ; Villa, Anna ; Asada, Hiroshi ; Kawai, Shin ; Ohashi, Yoshiyuki ; Takahashi, Miyoko ; Hakozaki, Ikuko ; Nitanai, Etsuko ; Minegishi, Masayoshi ; Tsuchiya, Shigeru. / Identification of anti-herpes simplex virus antibody-producing B cells in a patient with an atypical RAG1 immunodeficiency. In: Blood. 2001 ; Vol. 98, No. 5. pp. 1464-1468.
@article{ab81e2931c6641cdaed3c05526aba084,
title = "Identification of anti-herpes simplex virus antibody-producing B cells in a patient with an atypical RAG1 immunodeficiency",
abstract = "Mutations of the RAG1 or RAG2 protein that eliminate their recombination activity result in T-B-severe combined immunodeficiency (SCID), whereas mutations retaining partial recombination activity lead to Omenn syndrome, a peculiar SCID characterized by increased host T cells and absence of circulating B cells. The prognosis of this disease is fatal, unless hematopoietic stem cell transplantation is performed. This study reports a case of atypical SCID, carrying RAG1 mutations. The patient survived for 6 years without hematopoietic stem cell transplantation. The missense mutation, tested by in vivo recombination assay, revealed residual recombination activity. By the age of 5 years, the patient developed host B cells, but not T cells, possibly due to engrafted maternal T cells. In addition, the host B cells were able to produce antibodies, including anti-herpes simplex virus-antibodies. The fact that host B cells could produce antibodies in this patient could explain not only the mild phenotype observed but also, at least in part, how patients with Omenn syndrome produce immunoglobulin E and sometimes immunoglobulin M, as the same missense mutation of RAG1 gene has been reported in a patient with Omenn syndrome.",
author = "Satoru Kumaki and Anna Villa and Hiroshi Asada and Shin Kawai and Yoshiyuki Ohashi and Miyoko Takahashi and Ikuko Hakozaki and Etsuko Nitanai and Masayoshi Minegishi and Shigeru Tsuchiya",
year = "2001",
month = "9",
day = "1",
doi = "10.1182/blood.V98.5.1464",
language = "English",
volume = "98",
pages = "1464--1468",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "5",

}

TY - JOUR

T1 - Identification of anti-herpes simplex virus antibody-producing B cells in a patient with an atypical RAG1 immunodeficiency

AU - Kumaki, Satoru

AU - Villa, Anna

AU - Asada, Hiroshi

AU - Kawai, Shin

AU - Ohashi, Yoshiyuki

AU - Takahashi, Miyoko

AU - Hakozaki, Ikuko

AU - Nitanai, Etsuko

AU - Minegishi, Masayoshi

AU - Tsuchiya, Shigeru

PY - 2001/9/1

Y1 - 2001/9/1

N2 - Mutations of the RAG1 or RAG2 protein that eliminate their recombination activity result in T-B-severe combined immunodeficiency (SCID), whereas mutations retaining partial recombination activity lead to Omenn syndrome, a peculiar SCID characterized by increased host T cells and absence of circulating B cells. The prognosis of this disease is fatal, unless hematopoietic stem cell transplantation is performed. This study reports a case of atypical SCID, carrying RAG1 mutations. The patient survived for 6 years without hematopoietic stem cell transplantation. The missense mutation, tested by in vivo recombination assay, revealed residual recombination activity. By the age of 5 years, the patient developed host B cells, but not T cells, possibly due to engrafted maternal T cells. In addition, the host B cells were able to produce antibodies, including anti-herpes simplex virus-antibodies. The fact that host B cells could produce antibodies in this patient could explain not only the mild phenotype observed but also, at least in part, how patients with Omenn syndrome produce immunoglobulin E and sometimes immunoglobulin M, as the same missense mutation of RAG1 gene has been reported in a patient with Omenn syndrome.

AB - Mutations of the RAG1 or RAG2 protein that eliminate their recombination activity result in T-B-severe combined immunodeficiency (SCID), whereas mutations retaining partial recombination activity lead to Omenn syndrome, a peculiar SCID characterized by increased host T cells and absence of circulating B cells. The prognosis of this disease is fatal, unless hematopoietic stem cell transplantation is performed. This study reports a case of atypical SCID, carrying RAG1 mutations. The patient survived for 6 years without hematopoietic stem cell transplantation. The missense mutation, tested by in vivo recombination assay, revealed residual recombination activity. By the age of 5 years, the patient developed host B cells, but not T cells, possibly due to engrafted maternal T cells. In addition, the host B cells were able to produce antibodies, including anti-herpes simplex virus-antibodies. The fact that host B cells could produce antibodies in this patient could explain not only the mild phenotype observed but also, at least in part, how patients with Omenn syndrome produce immunoglobulin E and sometimes immunoglobulin M, as the same missense mutation of RAG1 gene has been reported in a patient with Omenn syndrome.

UR - http://www.scopus.com/inward/record.url?scp=0035469887&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035469887&partnerID=8YFLogxK

U2 - 10.1182/blood.V98.5.1464

DO - 10.1182/blood.V98.5.1464

M3 - Article

VL - 98

SP - 1464

EP - 1468

JO - Blood

JF - Blood

SN - 0006-4971

IS - 5

ER -